Liqomics

LIQOMICS pioneers in circulating tumor DNA (ctDNA) detection through non-invasive liquid biopsy methods. Our state-of-the-art technology identifies genetic alterations in the bloodstream, providing real-time insights into tumor dynamics. This enables clinicians to make informed decisions and tailor treatments effectively. Choose LIQOMICS for cutting-edge ctDNA analysis in cancer diagnostics.